Researchers found that a blood biomarker could help identify Alzheimer’s risk in cognitively healthy adults, though experts advise against routine screening.

University of Houston researchers are using advanced imaging to track CTR1 protein dynamics, identifying how cellular copper regulation may influence neurodegenerative disease.

Updated WHO guidelines shift the perception of dementia from an inevitable consequence of aging to a manageable public health priority.

The World Health Organization has updated its international guidelines, identifying 14 modifiable risk factors that influence the development of dementia. These findings provide a framework for public health policy and individual cognitive health management.

A Phase 1b trial of the immunotherapy IBC-Ab002 has successfully met safety endpoints, marking a potential shift in treating Alzheimer's as a systemic immune disorder.

The World Health Organization has released updated guidelines identifying modifiable health and lifestyle factors that can prevent or delay dementia. Researchers are also exploring new diagnostic blood tests and experimental drug therapies to address cognitive decline.

Researchers have unveiled mid-stage trial results for diranersen, an experimental drug that reduces abnormal tau production in Alzheimer’s patients.

A study tracking over 26,000 participants over three decades found that a Mediterranean diet is linked to cognitive benefits, particularly for APOE4 carriers.